Small/Micro Cap

The Acquirer’s Multiple® | |

Tobias chats with Jeff Gramm, Founder of Bandera Partners and author of Dear Chairman.

Ronald Woessner | |

OTC companies face an inhospitable environment of illiquidity, toxic capital and no research coverage.

Ronald Woessner | |

The liquidity—or lack thereof—of many small caps presents a big problem for companies and their current and potential investors.